Best CJC-1295 No DAC & Ipamorelin Dosage Fat Loss 2026: Research Protocol Comparison
Conservative Research Protocol 50mcg 200mcg 3x weekly (MWF) 8–12% visceral fat reduction in caloric deficit Lowest effective dose. Ideal for first-time researchers or those concerned about insulin sensitivity Standard Research Protocol 100mcg 12–18% visceral f
This comparison does not assign a generated winner or score.
- Conservative Research Protocol
- 50mcg
- 200mcg
- 3x weekly (MWF)
- 8–12% visceral fat reduction in caloric deficit
- Lowest effective dose. Ideal for first-time researchers or those concerned about insulin sensitivity
- Standard Research Protocol
- 100mcg
- 12–18% visceral fat reduction, improved fasted fat oxidation
- Most commonly cited in metabolic studies. Balances efficacy and peptide cost
- Aggressive Research Protocol
- 300mcg
- 5x weekly or daily (first 4 weeks)
- 15–22% visceral fat reduction, significant subcutaneous changes
- Higher peptide consumption; some researchers report mild water retention or carpal tunnel-like symptoms
- Extended Half-Life (DAC) Protocol
- 100mcg CJC + DAC
- 2x weekly
- 6–10% visceral fat reduction. Lower lipolytic response
- Convenience-focused but sacrifices pulsatile GH pattern; not recommended for fat loss-specific goals